✦ LIBER ✦

Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study

✍ Scribed by Paula M Fracasso; John A Blessing; Judith Wolf; Thomas F Rocereto; Jonathan S Berek; Steven Waggoner

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin plus gemcitabine in previously

✍ Cheryl A. Brewer; John A. Blessing; Robert A. Nagourney; D. Scott McMeekin; Shas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Evaluation of gemcitabine in previously

✍ Russell J. Schilder; John Blessing; David E. Cohn 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Topotecan in Squamous Cell Carcinoma of

✍ Michael A. Bookman; John A. Blessing; Parviz Hanjani; Thomas J. Herzog; Willie A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Evaluation of Gemcitabine in Patients wi

✍ Russell J. Schilder; John A. Blessing; Mark Morgan; Charles E. Mangan; Janet S. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Phase II Evaluation of Altretamine for A

✍ Peter G. Rose; John A. Blessing; James Arseneau 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A phase II trial of pyrazoloacridine (PZ

✍ Steven C. Plaxe; John A. Blessing; George Olt; Nader Husseinzadah; Samuel S. Len 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 71 KB